BMY vs FUNC · P/E 17, rev $48.19B vs P/E 10, rev $17.7M
Bristol-Myers Squibb Company (BMY) versus First United Corporation (FUNC) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
First United Corporation (FUNC) is a banks - regional company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FUNC revenue for 2024-12-31 was $17.7M. Net income was $20.6M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
Not investment advice. Open the BMY and FUNC stock pages for the full models.
Not investment advice.